Tweenvest Stocks

Virax Biolabs Group Limited (NasdaqCM: VRAX)

Health Care · Health Care Providers & Services · GB

$1.80

-3.74% today · -88.5% 1Y

Virax Biolabs Group Limited (NasdaqCM: VRAX) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.49M and employs 26 people.

Over the last twelve months the share price has lost 88.5%, trading between 1.81 and 21.75.

Tweenvest scores Virax Biolabs Group Limited across four factors: quality 36/100, value 40/100. Its strongest factor is value.

VRAX price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.49M
Revenue (TTM)
$12.42K
P/E
—
EPS
-12.64
Dividend yield
—
Beta (5Y)
1.39
52-week high
$21.75
52-week low
$1.81
Avg volume (3M)
—
Shares outstanding
796.99K
Employees
26
Next earnings
—

About Virax Biolabs Group Limited

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.

ISIN
KYG9495L1335
Founded
2013
Listed since
Jul 21, 2022
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Saroja Pharma Industries India LimitedNSEI: SAROJA$1.71MRs40.80+4.88%
Hedera Group AB (publ)OM: HEGR$1.64MSkr0.48+5.26%
Mono Pharmacare LimitedNSEI: MONOPHARMA$1.62MRs8.90+4.09%
Acro Biomedical Co., Ltd.OTCPK: ACBM$1.56M$——
Medical Marijuana, Inc.OTCPK: MJNA$1.39M$0.00-50.00%
Global Longlife Hospital and Research LimitedBSE: 543520$1.36MRs12.52+3.05%
Universal Ibogaine Inc.TSXV: IBO$1.14MCA$——
Arzneiwerk AG VIDADB: TLIK$1.13M€0.16+33.88%

Browse every Health Care Providers & Services company →

Figures last refreshed Oct 11, 2026.